The White House has revised its February 2026 factsheet on the interim India-US trade framework, softening procurement language from “committed” to “intends” regarding over US$500 billion in US goods.
India’s 2026 amendments to the New Drug and Clinical Trials (NDCT) Rules, 2019, materially improve the operating environment for pharmaceutical companies, contract manufacturers, and foreign investors by compressing approval timelines and reducing pre-licensing bottlenecks.
India’s Budget 2026-27 introduces a 2 percent safe harbor for bonded component warehousing and a five-year tax exemption for non-resident suppliers, offering transfer pricing certainty and strengthening India’s role in global manufacturing supply chains.
Antitrust regulator CCI has imposed a US$3.01 million fine on Intel Corporation for an India-specific warranty policy deemed discriminatory and restrictive of parallel imports. The ruling clarifies how dominance is assessed under Indian competition law and highlights key compliance risks global companies.
The Indian state of Uttar Pradesh has overhauled its Shops and Commercial Establishments Act, expanding statewide applicability and modernizing employer compliance. The latest updates include threshold-based coverage, digital registration, revised working hours, and stronger enforcement for businesses operating in the state.
India Briefing has developed into a premium source for insight on doing business in India. It publishes business news concerning foreign direct investment into India, including the most important tax, legal and accounting issues. The India Briefing Magazine was first published in 2009, and is contributed to by investment professionals based in India.
Subscribe now to receive our weekly India Edition newsletter. Its free with no strings attached.
Not convinced? Click here to see our recent edition of India Weekly.
Type keyword to begin searching...
Other Briefings